Prothrombin Time After Antibiotics: Why INR Can Rise

Categories
Articles
Coagulation Safety Lab Interpretation 2026 Update Patient-Friendly

Antibiotics can raise PT/INR through warfarin metabolism, vitamin K depletion, poor intake, diarrhoea, and the illness being treated. The result matters most when it changes quickly or appears alongside bleeding symptoms.

📖 ~11 minutes 📅
📝 Published: 🩺 Medically Reviewed: ✅ Evidence-Based
⚡ Quick Summary v1.0 —
  1. Prothrombin time usually runs about 11-13.5 seconds in adults not taking anticoagulants, but each laboratory must use its own range.
  2. INR after antibiotics can rise within 2-5 days when warfarin is combined with trimethoprim-sulfamethoxazole, metronidazole, or an azole antifungal.
  3. Vitamin K depletion is more likely after 7-14 days of broad-spectrum treatment, especially with diarrhoea, low food intake, liver disease, or frailty.
  4. Warfarin target INR is commonly 2.0-3.0; many mechanical mitral-valve regimens use 2.5-3.5.
  5. INR of 5.0 or higher without bleeding generally needs same-day anticoagulation advice; do not independently stop or double doses.
  6. Urgent care is needed for black stool, vomiting blood, coughing blood, a severe sudden headache, fainting, or head injury while anticoagulated.
  7. PT with normal aPTT often points toward warfarin effect, vitamin K deficiency, early liver synthetic dysfunction, or factor VII deficiency.
  8. Trend and timing matter: compare the INR with the pre-antibiotic value, antibiotic start date, missed meals, alcohol change, and new medicines.

Can antibiotics raise prothrombin time and INR?

Yes—antibiotics can raise prothrombin time and INR, particularly in people taking warfarin. The usual mechanisms are reduced vitamin K availability, slowed warfarin clearance, acute illness, diarrhoea, and eating far less than usual; the change can begin within 48-72 hours for a strong drug interaction, while gut-flora effects often take longer.

Prothrombin time laboratory analyzer measuring a coagulation sample beside an anticoagulant tablet
Figure 1: Coagulation analysis links a prolonged clotting result with medication review.

A prolonged prothrombin time means the laboratory sample took longer than expected to form fibrin after tissue-factor reagent was added. INR standardises that result across reagents, but it is not a universal measure of bleeding risk in someone who is not on warfarin. A high INR should be interpreted with platelet count, liver markers, symptoms, and the reason the test was ordered; our coagulation panel guide explains what a normal panel can still miss.

In my clinical practice, the most avoidable surprise is a patient who starts an antibiotic on Friday and waits until their routine INR check the following week. Kantesti is an AI blood test analyzer that places PT/INR beside medication dates, liver tests, and prior results, which helps identify a change that is real rather than a slightly different laboratory method.

Dr. Thomas Klein here: an INR rise after antibiotics is not proof that the antibiotic alone caused it. Fever, reduced appetite, two days of loose stool, and missed servings of vitamin-K-containing foods can all move the same result in the same direction. As of August 30, 2026, prompt retesting remains safer than trying to predict the exact size of the rise from the prescription label alone.

What PT and INR numbers mean after an antibiotic course

PT is reported in seconds, while INR is a calculation that makes PT results comparable across laboratories. Adults not taking warfarin commonly have an INR near 0.8-1.2, whereas a typical therapeutic warfarin target is 2.0-3.0.

Coagulation assay cuvette and laboratory sample illustrating prothrombin time and INR measurement
Figure 2: A clot-detection assay converts sample clotting time into an INR.

A PT of 16 seconds may be normal at one laboratory and flagged at another because thromboplastin reagents have different sensitivities. INR 0.8-1.2 is a common reference interval for people not using vitamin K antagonists, but the report’s own range is the one to use. For technical context, see our aPTT and clotting tests guide.

For most atrial fibrillation, deep-vein thrombosis, and pulmonary embolism indications, the target is INR 2.0-3.0. A mechanical mitral valve commonly requires 2.5-3.5, although the prescribed target belongs to the valve type and cardiology plan—not a generic internet rule. Holbrook et al. in the 2012 CHEST guideline recommend more frequent INR monitoring when interacting drugs are started or stopped.

A number just above target is usually a monitoring problem, not an emergency. A sharp climb from 2.3 to 4.8 in three days, however, tells a different clinical story than a stable 3.2 in someone whose target ceiling is 3.5. The rate of change often gives me more useful information than one isolated result.

Typical non-warfarin INR 0.8-1.2 Usually expected when hepatic synthesis and vitamin K availability are adequate.
Common warfarin target 2.0-3.0 Typical therapeutic range for many indications; verify the individual prescription target.
Above common target 3.1-4.9 Contact the anticoagulation service for dose-specific advice, especially after a new antibiotic.
Marked elevation 5.0 or higher Same-day clinical advice is generally needed; any significant bleeding warrants emergency assessment.

How antibiotics and vitamin K changes prolong PT

Antibiotics may prolong PT by reducing intestinal bacterial production of vitamin K and by making food intake unreliable. This mechanism is most plausible after broader-spectrum or longer courses, not after every single antibiotic dose.

Vitamin K food sources surrounding an anticoagulant monitoring sample in a clinical nutrition scene
Figure 3: Diet consistency and intestinal vitamin K availability affect warfarin response.

Vitamin K is needed to activate clotting factors II, VII, IX, and X; factor VII has a short half-life of roughly 4-6 hours, so PT can become abnormal before other clotting measurements. Food-derived vitamin K1 still matters more than bacterial production for many adults, but altered gut flora can become clinically relevant when intake is already poor.

I worry most about the combination of an antibiotic course, vomiting or diarrhoea, and an older person who has lived on tea, toast, and soup for several days. That pattern can create a functional vitamin K deficit even without warfarin. Review the practical food issue in our guide to vitamin K and warfarin.

Do not suddenly eliminate leafy greens to “help” a high INR. For warfarin users, consistent vitamin K intake is safer than swinging from large servings to none; the anticoagulation clinician adjusts warfarin to the established diet. Severe malabsorption, cholestasis, or prolonged fasting makes this advice more individual.

Which antibiotics interact most strongly with warfarin?

Trimethoprim-sulfamethoxazole, metronidazole, and azole antifungals are among the clearest warfarin antibiotic interaction concerns because they can inhibit warfarin metabolism. Macrolides, fluoroquinolones, some cephalosporins, and rifampicin can also alter INR, though the direction and magnitude vary.

Warfarin tablet and medication review tray beside a prothrombin time laboratory sample
Figure 4: Medication reconciliation identifies antibiotics that can destabilise warfarin dosing.

The S-enantiomer of warfarin is mainly metabolised by CYP2C9. Metronidazole and trimethoprim-sulfamethoxazole can inhibit this pathway, allowing more active warfarin to remain in circulation; fluconazole can have a similar effect. The rise may appear within 2-5 days, sometimes before gastrointestinal symptoms have settled.

Baillargeon et al. reported in The American Journal of Medicine that older adults on warfarin had a higher risk of hospitalisation for bleeding after exposure to several antibiotics, with the highest risks around known interacting classes. The clinically useful message is not that antibiotics are forbidden; it is that the INR plan must change when the prescription changes. Our blood test timeline guide helps document those dates.

Kantesti is an AI blood test interpretation platform that reads an INR shift alongside the recorded medicines and the baseline trend, rather than treating a single flagged value as a diagnosis. Rifampicin is a notable exception: it induces metabolism and can lower INR during treatment, then allow INR to rebound after it is stopped. That delayed rebound catches experienced clinicians too.

Is the higher INR from the infection or the antibiotic?

The infection and the antibiotic can both raise INR, so a medication interaction should not be assumed without reviewing the whole illness. Fever, reduced dietary vitamin K, dehydration, liver stress, and acetaminophen use can amplify warfarin effect independently.

Clinical illness monitoring scene with thermometer, hydration cup, and coagulation laboratory sample
Figure 5: Illness-related poor intake can amplify an INR rise during treatment.

Acute inflammation may change hepatic drug metabolism, while fever increases turnover of vitamin-K-dependent clotting factors. Diarrhoea lasting more than 24-48 hours can reduce vitamin K intake and absorption, especially when it limits normal meals. A person treated for pneumonia who is barely eating is not physiologically comparable to someone taking the same antibiotic for a minor skin condition.

When I review PT INR results, I ask about alcohol, paracetamol or acetaminophen amount, anti-inflammatory tablets, herbal products, and the exact first and last antibiotic doses. A daily acetaminophen intake above about 2 g for several consecutive days can itself raise INR in some warfarin users. For an isolated high PT with normal aPTT, see our focused cause-and-next-steps article.

A 67-year-old with a stable INR of 2.4 can reach 4.1 after three days of metronidazole and minimal food intake; that is a familiar scenario, not a moral failing or a reason to abandon infection treatment. Prescribers can often coordinate antibiotic selection and INR timing, but the infection still needs appropriate care.

When a prolonged PT suggests liver dysfunction instead

A prolonged PT after antibiotics may indicate impaired liver synthesis when it occurs with rising bilirubin, low albumin, or abnormal liver enzymes. Vitamin K deficiency and liver dysfunction can overlap, and PT alone cannot reliably separate them.

Anatomical liver cross-section showing clotting factor production relevant to prolonged prothrombin time
Figure 6: The liver synthesises several factors measured indirectly by prothrombin time.

The liver makes factors II, V, VII, IX, and X, and factor V is not vitamin-K-dependent. Clinicians sometimes use factor V, bilirubin, albumin, platelet count, and the response to supervised vitamin K to distinguish nutritional deficiency from reduced hepatic synthetic capacity. None of these is a stand-alone verdict.

Pale stool, dark urine, new jaundice, abdominal swelling, confusion, or rapidly worsening fatigue with a prolonged PT requires prompt medical assessment. A cholestatic pattern—raised alkaline phosphatase and GGT with direct bilirubin—can reduce absorption of fat-soluble vitamin K; our cholestasis pattern guide explains why that matters.

An INR above 1.5 in acute liver failure is clinically significant when accompanied by encephalopathy, but this is a hospital diagnosis, not something to self-diagnose from a portal result. Antibiotic-associated liver injury is uncommon, yet a new PT rise plus jaundice should never be brushed off as “just the medication.”

Who should have PT INR retested promptly after antibiotics?

Warfarin users who start, stop, or change a systemic antibiotic often need an INR check within about 3-5 days, with a second check during or shortly after treatment if risk remains. The exact schedule depends on the prior INR, antibiotic, indication, illness severity, and local anticoagulation protocol.

Patient hand scheduling a prompt prothrombin time retest beside an anticoagulation sample kit
Figure 7: Early retesting detects clinically meaningful INR movement before complications develop.

Highest-risk features include age over 75 years, previous unstable INR, chronic liver disease, kidney impairment, body weight loss, poor appetite, diarrhoea, active cancer, and a target above 3.0. An INR check within 48-72 hours is often reasonable after a high-risk interaction or already borderline-high result, but the prescribing service should make that call. Our kidney function after dehydration guide adds context when illness has also affected renal markers.

People not taking warfarin usually do not need routine PT INR testing simply because they received antibiotics. Testing is more appropriate when there is unexplained bruising, bleeding, jaundice, severe malnutrition, prolonged diarrhoea, known liver disease, or a clinician’s concern about coagulopathy.

Most patients find a written plan far more reassuring than generic warnings: date of first antibiotic dose, planned INR date, who calls with the result, and what symptoms override the plan. Kantesti is an AI-powered blood test analysis tool that can preserve this sequence across reports, but it cannot replace the clinician who adjusts anticoagulant treatment.

Could a high PT INR after antibiotics be a laboratory issue?

A surprising PT INR result can occasionally reflect sample collection or processing problems, but it must be treated as real until the laboratory or clinician confirms otherwise. An underfilled citrate tube is a classic cause of falsely prolonged clotting times.

Citrate coagulation tube being prepared for prothrombin time testing in a clean laboratory
Figure 8: Correct citrate sample filling is essential for reliable clotting-time measurement.

Coagulation tubes require a precise 9-to-1 ratio of laboratory sample to sodium citrate anticoagulant. Underfilling leaves excess citrate relative to the sample and can falsely prolong PT and aPTT. A very high haematocrit, generally above 55%, also needs citrate adjustment because plasma volume is lower.

Direct oral anticoagulants complicate interpretation: apixaban, rivaroxaban, dabigatran, and edoxaban are not monitored with INR, and a normal or abnormal PT does not measure their anticoagulant effect reliably. If the clinical question is anticoagulant activity rather than warfarin monitoring, the laboratory may need a drug-specific assay. Our mixing-study explanation describes one specialised approach to unexplained prolongation.

Repeat testing is sensible when the result conflicts with the clinical picture, but not as a reason to delay care for active bleeding. I have seen a malformed sample explain a mild INR discrepancy; I have also seen “probably a lab error” become a dangerous assumption in a person with black stool.

What not to do when INR rises during antibiotics

Do not independently skip several warfarin doses, take vitamin K supplements, or double a later dose after an elevated INR unless your anticoagulation clinician gives explicit instructions. These reactive changes can create a swing from excess anticoagulation to clot risk.

Careful anticoagulant medication plan beside vitamin K foods and prothrombin time sample
Figure 9: Medication and dietary changes require coordinated anticoagulation advice.

A common mistake is treating greens as the enemy. A sudden large vitamin K increase can lower INR and reduce warfarin effect, while abruptly avoiding usual vegetables can push INR higher. The safer approach is to keep food patterns steady and report any sustained dietary change to the team managing warfarin.

Over-the-counter ibuprofen, naproxen, aspirin, and many combination cold remedies can increase bleeding risk without necessarily changing INR. Antibiotic-associated nausea also prompts some people to use bismuth products, which can darken stool and confuse assessment; true tarry stool remains a warning sign. Read our practical note on vitamin K2 supplement safety before adding any supplement.

Vitamin K reversal is a medication decision, not a wellness intervention. Low oral doses such as 1-2.5 mg may be used in selected non-bleeding patients with excessive INR under protocol, while major bleeding requires emergency treatment with intravenous vitamin K and clotting-factor replacement. The dose and route matter enormously.

When a high PT INR after antibiotics needs urgent care

Emergency assessment is needed for significant bleeding or neurological symptoms at any INR, not only above a particular number. Black tarry stool, vomiting or coughing blood, heavy uncontrolled bleeding, a sudden severe headache, fainting, confusion, or any head injury while anticoagulated are urgent red flags.

Emergency anticoagulation safety assessment with prothrombin time results and clinical monitoring equipment
Figure 10: Bleeding symptoms outweigh the INR number when deciding on emergency assessment.

An INR of 5.0 or higher without bleeding generally warrants same-day contact with the anticoagulation clinic, prescriber, or urgent service for individualised direction. An INR above 8.0, even without obvious bleeding, is commonly managed urgently because the chance of serious bleeding rises as anticoagulant intensity increases. Local protocols differ, so a lab flag is not itself a dosing instruction.

New severe back pain, large spontaneous bruises, red or brown urine, prolonged nosebleeds lasting over 20 minutes, or bleeding that will not stop with firm pressure deserve prompt advice. In older adults, a fall with head impact can be serious despite feeling well initially. The relevant question is exposure to anticoagulation plus symptoms, not whether there is visible external injury.

A normal platelet count does not cancel a high INR, and a normal INR does not rule out bleeding from an ulcer or other cause. For broader emergency-lab context, our electrolyte and urgent-care guide shows why clinicians assess clusters rather than one number.

A practical retesting plan after a warfarin antibiotic interaction

A safe retesting plan records the baseline INR, antibiotic timing, illness symptoms, diet change, and the next test date before the first dose whenever possible. For a stable warfarin user starting a known interacting antibiotic, checking around day 3 and again near treatment completion is a common clinical pattern.

Longitudinal prothrombin time trend review on a tablet beside dated laboratory samples
Figure 11: Serial results reveal whether INR movement follows medication and illness timing.

The first retest should be earlier when baseline INR is near the top of range, the antibiotic inhibits CYP2C9, intake is poor, or a prior interaction occurred. A second INR 3-7 days after antibiotic completion can be useful, particularly after fluconazole or rifampicin, because drug effects and diet may change again. The correct interval is personalised.

Kantesti AI interprets PT INR results by comparing the reported value with prior results, drug timing, and companion markers such as bilirubin, albumin, and platelets. That longitudinal view is why meaningful lab-change analysis is often more useful than simply asking whether today’s value has an H flag.

Dr. Thomas Klein’s practical checklist is brief: photograph every medicine box, record the last warfarin dose, report diarrhoea and missed meals honestly, and use the same laboratory if feasible. Do not wait for symptoms if the clinician has asked for an early INR; serious bleeding is precisely what monitoring is meant to prevent.

Special situations: children, pregnancy, older age, and DOACs

Children, pregnant patients, frail older adults, and people using direct oral anticoagulants need interpretation that is more individual than a standard adult warfarin chart. INR targets, antibiotic choice, nutritional reserve, and reasons for PT testing differ substantially across these groups.

Multigenerational clinical consultation reviewing prothrombin time safety with laboratory results
Figure 12: Age, pregnancy, frailty, and anticoagulant type change the interpretation plan.

In children, PT reference intervals vary by age and neonatal physiology, and antibiotic-related vitamin K deficiency is more concerning with prolonged poor feeding, cholestasis, or malabsorption. Newborns are not small adults for coagulation testing, so paediatric teams should set the retesting threshold. Our pregnancy blood-test red flags guide covers when same-day obstetric review is appropriate.

Pregnancy increases clotting tendency, but warfarin crosses the placenta and is generally avoided except in specialised circumstances such as some mechanical valves. A prolonged PT in pregnancy can reflect nutritional, hepatic, obstetric, or medication issues and deserves clinician-led evaluation rather than dietary self-treatment.

For DOAC users, antibiotics such as clarithromycin and azole antifungals may alter drug levels through P-glycoprotein or CYP3A4 pathways, but INR is not the monitoring tool for DOAC dose effect. Tell the prescriber about every antimicrobial, including antifungal tablets and herbal products.

How to interpret a PT INR result in clinical context

The safest interpretation combines the PT INR value with anticoagulant type, symptoms, liver function, platelet count, nutrition, and the time course of medication changes. A result is a signal for a clinical decision, not a dose instruction by itself.

Clinician reviewing integrated prothrombin time, liver panel, and medication trend information
Figure 13: Contextual interpretation connects INR changes with companion laboratory markers.

Kantesti uses structured extraction to identify whether a report says PT in seconds, INR, or both, then compares the stated laboratory interval with prior reports. Kantesti is an AI lab test interpretation service that highlights the combination of rising INR, falling albumin, or raised bilirubin as a follow-up pattern, rather than claiming that one measurement establishes the cause.

The most meaningful companion tests are often CBC and platelets for occult blood-loss clues, ALT/AST/ALP/GGT/bilirubin for hepatic or cholestatic patterns, albumin for nutritional or chronic hepatic context, and creatinine for medication safety. A normal aPTT beside prolonged PT narrows the differential but does not remove the need to assess warfarin and vitamin K exposure.

Clinical accuracy requires humans in the loop. Our medical validation standards describe how result interpretation is designed to support—not substitute for—qualified medical assessment, particularly when a medicine may need urgent adjustment.

Questions to ask the prescriber or anticoagulation clinic

Ask whether the antibiotic is expected to interact with your specific anticoagulant, when to recheck INR, and what result or symptom should trigger an urgent call. Clear questions reduce accidental dose changes and missed monitoring during a short, disruptive illness.

Patient medication questions beside an anticoagulation clinic laboratory sample and appointment notes
Figure 14: Specific questions turn an abnormal INR into a safer follow-up plan.

Useful wording includes: “My last INR was 2.6; when should I test after starting this drug?” and “Should I continue my usual vitamin K foods while I am unwell?” Also ask whether anti-nausea drugs, pain relievers, or antifungal treatment alter the plan. The name, dose, and duration of the antibiotic are all clinically relevant.

If a result arrives before the clinician has called, write down the INR, PT seconds, date and time of collection, recent warfarin doses, and any bleeding symptom. This is more helpful than guessing whether a value is “only a little high.” Our doctor-visit result summary checklist can make that conversation shorter and safer.

Kantesti’s physician-led approach includes review principles set by our Medical Advisory Board. Even so, a patient with active bleeding should contact emergency services rather than wait for a digital interpretation or routine appointment.

Research, clinical limits, and the bottom line

Antibiotic-related INR elevation is usually manageable when it is anticipated, retested early, and acted on through the clinician who prescribed or monitors anticoagulation. The danger comes from assuming that a familiar antibiotic, a mild illness, or a single prior stable INR guarantees safety.

The CHEST evidence-based guideline by Holbrook et al. supports closer INR surveillance when interacting drugs are added or withdrawn, while Baillargeon et al. documented clinically relevant bleeding risk after antibiotic exposure in older warfarin users. Evidence on how much gut-flora change alone contributes is honestly mixed, because illness, food intake, and prescribing selection are difficult to disentangle in real patients.

Kantesti supports multilingual interpretation across laboratory formats, but no AI can determine a safe warfarin dose from a photograph of one report. If there is bleeding, a rapidly rising INR, jaundice, confusion, or a head injury, use urgent clinical care. For the people and clinical oversight behind this work, see our medical team.

Klein, T. (2026). Women’s Health Guide: Ovulation, Menopause & Hormonal Symptoms. Figshare. https://doi.org/10.6084/m9.figshare.31830721. ResearchGate Academia.edu. Klein, T. (2026). Multilingual AI Assisted Clinical Decision Support for Early Hantavirus Triage: Design, Engineering Validation, and Real-World Deployment Across 50,000 Interpreted Blood Test Reports. Figshare. https://doi.org/10.6084/m9.figshare.32230290. ResearchGate Academia.edu.

Frequently Asked Questions

How soon can antibiotics affect INR on warfarin?

Antibiotics can affect INR within 2-5 days when they inhibit warfarin metabolism, particularly trimethoprim-sulfamethoxazole, metronidazole, or azole antifungals. Gut-flora and nutrition effects may take 7-14 days, especially during prolonged treatment with poor food intake or diarrhoea. A stable warfarin user commonly needs an INR plan within about 3-5 days of starting a meaningful interaction. The prescriber or anticoagulation clinic should set the exact timing.

Can antibiotics raise INR if I do not take warfarin?

Yes, antibiotics can occasionally raise INR in someone not taking warfarin, usually through vitamin K deficiency, liver injury, severe diarrhoea, malabsorption, or critical illness. An INR above the laboratory reference range of roughly 0.8-1.2 is not expected simply from a routine short course in an otherwise well adult. Unexplained bruising, black stool, jaundice, or a PT that remains prolonged after treatment needs medical assessment. The result may require liver tests, CBC, medication review, and repeat coagulation studies.

What INR is too high after antibiotics?

For many warfarin indications, INR above 3.0 is above target, but urgency depends on the prescribed range, speed of increase, and bleeding symptoms. INR of 5.0 or higher without bleeding generally requires same-day advice from an anticoagulation service, while INR above 8.0 is commonly managed urgently. Any major bleeding, severe headache, fainting, confusion, or head injury warrants emergency assessment regardless of the INR number. Do not alter warfarin doses without specific medical direction.

Should I take vitamin K when my INR rises after antibiotics?

Do not take vitamin K supplements for a high INR unless a clinician directs the dose and route. Small oral doses of 1-2.5 mg are used under selected protocols for excessive INR without bleeding, but unsupervised vitamin K can overcorrect anticoagulation and increase clot risk. Keep your normal diet reasonably consistent rather than suddenly removing or loading leafy greens. Emergency bleeding treatment requires hospital-directed therapy, not over-the-counter supplements.

Does amoxicillin interact with warfarin?

Amoxicillin has a less predictable warfarin interaction than metronidazole or trimethoprim-sulfamethoxazole, but INR can still rise during amoxicillin treatment because infection, reduced food intake, diarrhoea, and altered vitamin K availability often occur together. The risk is higher in people older than 75 years, with liver disease, poor nutrition, or a previously unstable INR. A check around day 3-5 may be advised for a warfarin user, depending on baseline control and illness severity. Never assume a common antibiotic is interaction-free.

Why is PT high but aPTT normal after antibiotics?

A prolonged PT with normal aPTT often reflects reduced factor VII activity because factor VII is part of the extrinsic pathway and has a short half-life of about 4-6 hours. Warfarin effect, early vitamin K deficiency, early liver synthetic dysfunction, and rarely congenital factor VII deficiency are common considerations. Antibiotics can contribute through warfarin interaction or nutritional disruption, but they are not the only cause. Repeat testing and a medication-plus-liver review are usually more informative than interpreting the pattern alone.

Get AI-Powered Blood Test Analysis Today

Join over 2 million users worldwide who trust Kantesti for instant, accurate lab test analysis. Upload your blood test results and receive comprehensive interpretation of 15,000+ biomarkers in seconds.

📚 Referenced Research Publications

1

Klein, T., Mitchell, S., & Weber, H. (2026). Women's Health Guide: Ovulation, Menopause & Hormonal Symptoms. Kantesti AI Medical Research.

2

Klein, T., Mitchell, S., & Weber, H. (2026). Multilingual AI Assisted Clinical Decision Support for Early Hantavirus Triage: Design, Engineering Validation, and Real-World Deployment Across 50,000 Interpreted Blood Test Reports. Kantesti AI Medical Research.

📖 External Medical References

3

Holbrook A et al. (2012). Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed.. Chest.

4

Baillargeon J et al. (2012). Risk of bleeding with exposure to warfarin and antibiotics in older adults. The American Journal of Medicine.

2M+Tests Analyzed
127+Countries
75+Languages

⚕️ Medical Disclaimer

E-E-A-T Trust Signals

Experience

Physician-led clinical review of lab interpretation workflows.

📋

Expertise

Laboratory medicine focus on how biomarkers behave in clinical context.

👤

Authoritativeness

Written by Dr. Thomas Klein with review by Dr. Sarah Mitchell and Prof. Dr. Hans Weber.

🛡️

Trustworthiness

Evidence-based interpretation with clear follow-up pathways to reduce alarm.

🏢 Kantesti LTD Registered in England & Wales · Company No. 17090423 London, United Kingdom · kantesti.net
blank
By Prof. Dr. Thomas Klein

Dr. Thomas Klein is a board-certified clinical hematologist serving as Chief Medical Officer at Kantesti AI. With over 15 years of experience in laboratory medicine and a strong interest in AI-supported interpretation of blood test results, he works to connect new technology with everyday clinical practice. His areas of interest include biomarker analysis, clinical decision support research and population-specific reference range optimization. As CMO, he contributes clinical input to the platform's internal benchmarking and provides clinical oversight for the medical quality of Kantesti's educational reports.

Leave a Reply

Your email address will not be published. Required fields are marked *